Canada must ensure all orphan drugs are priced fairly to allow patient access

23 febrero 2015

In developing an orphan drug policy, Canada must ensure that all orphan drugs for rare diseases — both old and future drugs — should be priced fairly so that Canadians may access life-saving therapy, argue authors of a new Canadian analysis.